DAFTAR PUSTAKA

1. Dhibi M, Brahmi F, Mnari A, Houas Z, Chargui I, Bchir L, at al. The intake of

high fat diet with different trans fatty acid levels differentially induces
oxidative stres and non alcoholic fatty liver disease (NAFLD) in rats. Nutr
Metab (Lond). 2011 23;8(1):65.

2. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, at al.

Non alcoholic fatty liver disease and mortatilty among US adults : prospective
cohort study.BMJ 2011:343 : 6891

3. Sey AV. Nonalcoholic fatty liver disease: Epidemiology and diagnosis

Hepatol 2003; 37: 917-23.

4. Hasan , Lesmana LR, Gani RA, Machmud R, Akbar N, and Noer HMS. et al.
Prevalance and risk factors for non alcoholic fatty liver in Indonesia. PIN XIV
PPHI, Konas XIII PGI-PEGI, Surabaya 2007

5. Adams LA, Sanderson S, Lindor KD, and Angulo P. The histological course
of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with
sequential liver biopsies. J Hepatol 2005 ;42:132-8.

6. Chavez NN, Uribe M, Ponciano RG, Medina SR, and Mendez SN: New
insights into the pathophysiology of nonalcoholic fatty liver disease. Ann
Hepatol 2009, 8:S9-S17.

7. Abrams GA, Kunde SS, Lazenby AJ, Clements RH: Portal fibrosis and
hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty
liver disease. Hepatol 2004. 40:475-83.

8. Brunt EM: Nonalcoholic steatohepatitis: pathologic features and differential

diagnosis. Semin Diagn Pathol 2005, 22:330-8.

9. Brunt EM, Tiniakos DG. Histopathology of Nonalcoholic fatty liver disease.

World J Gastroenterol 2010: 16(42) : 5286-96

10. Martínez MG, García VE, Anell MV, Cravioto MG, González J, and
Alvarenga JC. at al. Dietary trans fatty acids and its metabolic implications.
Gac Med Mex 2010: 146(4):281-8.

11. Askandar T. The metabolic syndrome ( The mets ). Anticipating Style Related
Disease. Sumetsu-1 2005, vii

80
12. Laporan pelaksanaan surkesda, Dinas Kesehatan Jogya [Internet ] 2008 [ cited
2011 May 10] Available from http//www.dinkes.jogjaprov.go.id

13. Sartika RAD, Pengaruh asam Lemak Jenuh, Tidak Jenuh dan Asam Lemak
Trans terhadap Kesehatan, Jurnal Kesehatan Masyarakat nasional, 2008 ; 4 (2
) : 154-9

14. Safwat GM, Pisanò S, D'Amore E, Borioni G, Napolitano M, Kamal AA,

at.al: Induction of non-alcoholic fatty liver disease and insulin resistance by
feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a
modulatory effect? Nutr 2009, 25:1157-68.

15. Cano A, Ciaffoni F, Safwa GM, Aspichueta P, Ochoa B, Bravo E, at al :

Hepatic very low density lipoprotein assembly is disturbed in a rat model of
non alcoholic fatty liver disease: Is there a role for dietary Coenzyme Q? J
Applied Physiol 2009, 107:707-17

16. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma
markers of inflammation in healthy men fed controlled diets: a randomized
crossover study. Am J Clin Nutr. 2004 :79(6):969-73.

17. Sung NH, Lynette SL,Alice HL, Lynne MA, Ernst JS, and Simin NM. at.al.
Effect of hydrogenated and saturated, relative to polyunsaturated, fat on
immune and inflammatory responses of adults with moderate
hypercholesterolemia. J Lipid Res 2002 : 43 (3), 445-52.

18. Dorfman SE, Laurent D, Gounarindes, Li X, Mullarkey TL, and Rocheford

EC. at.al. Metabolic implication of dietary trans fatty acid. Obesity J org. 2009
: 17 (6) ; 1200-7

19. Sean WP, Koppe, Marc E, Richard H, Moseley, and Richard M. at al. Trans
fat feeding results in higher serum alanine aminotransferase and increased
insulin resistance compared with a standard murine high fat diet. Am J Physiol
Gastrointest Liver Physiol. 2009: 297 : G378.

20. Roberta MM, Jose TS, Claudia PM, Evandro SM, Fabiana DF, Valeria SN,
at.al. Intake of trans Fatty Acids Causes Nonalcoholic Steatohepatitis and
Reduces Adipose Tissue Fat content J. Nutr. 2011 ; 140: 1127–32.

21. Adams LA, Angulo P: Recent concepts in non-alcoholic fatty liver disease.
Diabetic Med 2005, 22:1129-33.

22. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized
cause of cryptogenic cirrhosis. JAMA2003;289:3000-4.

81
23. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic
fatty liver disease: a clinical histopathological study. Am J Gastroenterol.
2003;98:2042-7.

24. Sears D . Fatty Liver,[online]. [ Internet ] 2011 [ Cited 2012 january 5 ].

Available from : www.emedicine.com.

25. Carithers & McClain. Alcoholic Liver Disease. In:textbook of Gastrointestinal

and Liver Disease. 9th edition. Philadelphia. Saunders Elsevier Publishing ;
2010. p: 1383-400

26. Fairbank KD. Alcoholic Liverv Disease.[ Internet ] 2010 [cited 2012 january
5 ] Available from : www.clevelandclinicmeded.com

27. Zivkovic AM, German JB and Sanyal AJ. Comparative review of diets for the
metabolic syndrome: implications for nonalcoholic fatty liver disease
Am J Clin Nutr 2007 ;86 (2); 285-300.

28. Pessayre D. Role of mitochondria in non-alcoholic fatty liver disease. Am J

Gastroenterol 2007 ; 22: S20-7.

29. Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and
mitochondrial dysfunction. World J Gastroenterol. 2008 ;14:193–9.

30. Angulo P. .The Nonalcoholic fatty liver disease. Hepatol 2002 ; 45:1221-31.

31. Hasan I. Perlemakan hati non alkohol. edisi 5 th Dalam: Buku ajar Ilmu
Penyakit Dalam Interna. Editor, Aru W sudoyo dkk. Jakarta.Penerbit EGC.
2010. p. 695-70112.

32. Lesmana LA. Penyakit Perlemakan Hati non Alkoholik. Dalam: Ilmu Penyakit
Hati. Jakarta. Penerbit Jaya Abadi.2007.hal :301-5

33. Liu Q, Bengmark S and Qu S. The role of hepatic fat accumulation in

pathogenesis of non alcoholic fatty liver ( NAFLD ) Lipids in Health and
Disease 2010, 9:42

34. Ilyas T, hanefi O, Cevat T, and Ismail U. The serum level of IL-1 b, IL-6, IL-8
and TNF-a in nonalcoholic fatty liver. Turk J Med Sci 2003 :33 381-6.

35. Clark JM, Frederic L, Brancanti and Diel AM. Non alcoholic fatty liver
disease. Gastroenterol 2002 : 122: 1649-57

36. Videla LA, Rodrigo R, Araya J, Poniachik J: Oxidative stres and depletion of
hepatic longchain polyunsaturated fatty acids may contribute to nonalcoholic
fatty liver disease. Free Radic Biol Med 2004 , 37:1499-507.

82
37. Videla LA, Rodrigo R, Araya J, Ponichik J: Insulin resistance and oxidative
stres interdependency in non-alcoholic fatty liver disease. Trends Mol Med ,
12:555-8.

38. Gasbarrini V, Vero L, Miele AF, Hernandez, Greco, Gasbarrini A. at al.

Nonalcoholic fatty liver disease: defining a common problem. The European
Review for Medical and Pharmacological Sciences 2005; 9: 253-9

39. Murray, RK. Biokimia Harper edisi 25. Jakarta.EGC.2005

40. Brehm BJ. Trans Fatty Acid : Coming Soon to your Food Labels. In Diet and
Nutrition. University of Cincinanty. 2003

41. Inis SM. The Trans Fat Acid Composition and Content of Canadian Foods in
Child and Family Research Institute Nutrition Research Program. University
British Columbia. JADA 2001

42. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M,
Ehnholm C. at al. Effect of Diiferent forms of Dietary Hydrogenated Fats on
LDL Particel Size. Am J Clin Nutr 2003 : 78:370-5.

43. Wardlaw. Lipids in Perspectivies in Nutrition. 6 th ed . Boston.Mc Graw Hill.

2004 : p.177-210.

44. Dijkstra, Albert J. Hamilton RJ. Richard J, Hamm, Wolf. at al. Properti of
trans fat in trans fatty. New Delhi. Blackwell publishing Ltd. 2008, p.15-9

45. Kevin AH, Tyler A, Tamkeen R, Caryl A, Steven JM, Rafat AS.at.al. Trans-
fatty acids induce pro-inflammatory responses and endothelial cell
dysfunction. Br J Nutr 2007 : 99: 723–31.

46. Sartika RAD. Pengaruh suhu dan lama proses menggoreng (deep frying)
terhadap pembentukan asam lemak trans. MAKARA SAINS 2009; 13 : 23-8

47. Seonhye P, Yongsoon P. Effects of dietary fish oil and trans fat on rat aorta
histopahology and cardiovascular risk markers. Nutr Res Pract. 2009 Summer;
3(2): 102–7.

48. Wardlaw GM, and Kessel MW. 2002. Perspectives in Nutrition. 5 th edn.
Sydney. 2002.p. 226-7

49. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty
acids and cardiovascular disease. N Engl J Med. 2006: 13;354(15):1601-13.

83
50. Mensink RP, Zock PL, Kester ADM & Katan MB. Effects of dietary fatty
acids and carbohydrates on the ratio of serum total to HDL cholesterol and on
serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J
Clin Nutr :77, 1146–55.

51. Abbas AK, Litcman AH. Basic Immunology Update 2nd Ed. Philadelpia :
WB Saunders Company, 2006

52. Youssef W, McCullough AJ. Diabetes mellitus, obesity, and hepatic steatosis.
Semin Gastrointest Dis 2002 ;13: 17-30,

53. Tilg H, Diehl AM. Cytokines in alcoholic and non-alcoholicsteatohepatitis. N

Engl J Med 2000 343: 1467-76,

54. dibi , Niu SL, Mitchell DC, Litman BJ: Trans fatty acid derived phospholipids
show increased membran cholesterol and reduced receptor activation
as compared to their cis analogs. Biochem 2005, 44:4458-65.

55. Droge W. Free radicals in the physiological control of cell function. Physiol
Rev. 2002;82:47-95.[PubMed],

56. Soekidjo N. Metode penelitian eksperimen. Dalam metode penelitian

kesehatan. Rineka cipta. 2010 : 50-9

57. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, at al.
Dietary fat intake and risk of type 2 diabetes in woman. Am J Clin nutr
2001;73:1019-26

58. Almatsier S. Prinsip Dasar Ilmu Gizi. Jakarta: PT Gramedia Pustaka.2004

59. Pauline K, Nain-Feng C,Donna S, Bernard R, Graham C, Walter W. at al.

Prospective study of the association of changes in dietary intake, physical
activity, alcohol consumption, and smoking with 9-y gain in waist
circumference among 16 587 US men. Am J Clin Nutr . 2003 ; 78 :. 4 719-27

60. Kavanagh K, Jones KL, Sawyer J, Kelley K, Carr JJ, Wagner JD, Rudel
LLTrans fat diet induces abdominal obesity and changes in insulin sensitivity
in monkeys. Obesity (Silver Spring). 2007 Jul;15(7):1675-84.

61. Wolowczuk I, Verwaerde C, Viltart O, Delanoye A, Delacre M, Pot B. at.al.

Feeding our immune system: impact on metabolism. Clin Dev Immunol 2008;
2008: 639-803

62. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human
liver. Immunol Rev 2000; 174: 5-20

84
63. Gutteridge JM, Halliwell B: Free radicals and antioxidants in the year 2000: a
historical look to the future. Ann N Y Acad Sci 2000, 899:136-47.

64. Wei Y, Clark SE, Morris EM, Thyfault JP, Uptergrove GM, Whaley AT.at.al.
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by
oxidative stres in transgenic TG(mRen2)27(Ren2) rats. J Hepatol 2008; 49:
417-28

85